Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes CLBS12, CLBS14, CLBS16 and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.